All In Biotech

Free tool

FAERS Monitor: Remodulin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021272 or its brand name (Remodulin, Treprostinil). Reports on generic versions are filed under their own applications.

Reports

65,346

Serious

41,979

64% of reports

Hospitalization

31,164

Death reported

9,061

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea9,904
  • headache7,178
  • diarrhoea6,904
  • nausea6,212
  • infusion site pain5,788
  • death5,236
  • fatigue4,101
  • dizziness3,852
  • vomiting3,407
  • infusion site erythema3,353
  • pain in extremity2,976
  • hypotension2,834
  • pulmonary arterial hypertension2,822
  • malaise2,816
  • pneumonia2,688

Reports by year received

View as table
YearReports
200435
200562
200688
200743
200836
200971
2010900
20111,625
2012657
20131,002
20144,603
20155,481
20164,840
20174,855
20185,311
20194,970
20204,272
20214,041
20224,380
20235,081
20244,633
20254,928
20263,432

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,988,813 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion site painSignal5,788261.4252.7828,128
infusion site erythemaSignal3,353211.8202.9423,913
pulmonary arterial hypertensionSignal2,82277.674.5171,886
dyspnoeaSignal9,9045.75.638,882
hypotensionSignal2,8344.64.47,939
headacheSignal7,1783.73.614,517
diarrhoeaSignal6,9043.53.412,380
pain in extremitySignal2,9763.33.24,716
pneumoniaSignal2,6882.72.62,864
nauseaSignal6,2122.52.55,969
dizzinessSignal3,8522.52.43,513
vomitingSignal3,4072.32.32,659
malaiseSignal2,8162.12.01,587
death5,2362.01.92,559
fatigue4,1011.71.61,218

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.